UK

What a draft Brexit agreement means for the medical device industry
What a draft Brexit agreement means for the medical device industry
Emergo
devices
UK
Europe
Brexit
Flag link:
While controversy over Brexit reaches full boil, a pharma trade group sees the upside in a draft deal
While controversy over Brexit reaches full boil, a pharma trade group sees the upside in a draft deal
Endpoints
Brexit
UK
pharma industry
NHS
ABPI
Flag link:
Pfizer falls short in U.K. patent appeal for blockbuster Lyrica
Pfizer falls short in U.K. patent appeal for blockbuster Lyrica
Fierce Pharma
Pfizer
patents
UK
Lyrica
Flag link:
Biopharma may have to wait for Brexit details
Biopharma may have to wait for Brexit details
BioCentury
Brexit
Europe
UK
Flag link:
Half of Clinical Trials Fail to Publish Results, UK Report Finds
Half of Clinical Trials Fail to Publish Results, UK Report Finds
RAPS.org
clinical trials
UK
Europe
transparency
Flag link:
Sponsored: Pharma Supply Chain and Quality Experts Can Stay on Top of Their Game at Temperature Controlled Logistics Event
Sponsored: Pharma Supply Chain and Quality Experts Can Stay on Top of Their Game at Temperature Controlled Logistics Event
CP Wire
supply chain
UK
quality
Flag link:
Sponsored: Pharma Supply Chain and Quality Experts Can Stay on Top of Their Game at Temperature Controlled Logistics Event
supply chain
UK
quality
Flag link:
What does Brexit mean for clinical research?
What does Brexit mean for clinical research?
Mass Device
Brexit
UK
clinical trials
Flag link:
What “no-deal” Brexit means for medical devices
What “no-deal” Brexit means for medical devices
Emergo
UK
Europe
Brexit
devices
Flag link:
AZ to continue with investment freeze following ‘no deal’ Brexit
AZ to continue with investment freeze following ‘no deal’ Brexit
Pharmaforum
AstraZeneca
drug manufacturing
Brexit
UK
Flag link:
UK clinical trials fall as Brexit clouds drug approval process
UK clinical trials fall as Brexit clouds drug approval process
Reuters
UK
Brexit
clinical trials
Flag link:
NHS, Gilead reach agreement for Yescarta
NHS, Gilead reach agreement for Yescarta
BioCentury
Yescarta
Gilead Sciences
UK
NHS
CAR-T
Flag link:
Alnylam seeks MHRA approval to start ALN-AAT02 phase 1/2 trial
Alnylam seeks MHRA approval to start ALN-AAT02 phase 1/2 trial
Pharmaceutical Business Review
Alnylam
RNAi
ALN-AAT02
MHRA
UK
Flag link:
UK alarm bells are ringing as a biotech cuts a few trial sites, fretting over Brexit’s impact on drug development
UK alarm bells are ringing as a biotech cuts a few trial sites, fretting over Brexit’s impact on drug development
Endpoints
Brexit
UK
clinical trials
Recardio
Flag link:
Novartis, Bayer consider appeal as court says Avastin can be used in AMD
Novartis, Bayer consider appeal as court says Avastin can be used in AMD
Pharmaforum
UK
Roche
Avastin
wet age-related macular degeneration
Novartis
Bayer
Flag link:
AstraZeneca CEO warns of medicine shortages after Brexit: Sunday Times
AstraZeneca CEO warns of medicine shortages after Brexit: Sunday Times
Yahoo/Reuters
UK
Brexit
AstraZeneca
Pascal Soriot
drug shortages
Flag link:
NICE rejects Novartis’ CAR-T in adult lymphoma
NICE rejects Novartis’ CAR-T in adult lymphoma
Pharmaforum
NICE
UK
Novartis
CAR-T
Kymriah
NHS
diffuse large B-cell lymphoma
Flag link:
Novo Nordisk CEO reassures UK patients over Brexit insulin supplies
Novo Nordisk CEO reassures UK patients over Brexit insulin supplies
Pharmaforum
Novo Nordisk
insulin
UK
Brexit
Flag link:
UK ‘less interesting’ to pharma because of Brexit – Roche CEO
UK ‘less interesting’ to pharma because of Brexit – Roche CEO
Pharmaforum
Brexit
Roche
Severin Schwan
UK
Flag link:
MS Society protests NICE rejection of Ocrevus for primary progressive MS
MS Society protests NICE rejection of Ocrevus for primary progressive MS
BioCentury
NICE
UK
MS
multiple sclerosis
Ocrevus
ocrelizumab
Roche
Flag link:

Pages